超声透颅植入物:神经外科患者管理未来的窗口?系统综述与成本分析
该系统综述纳入5项研究共90例接受超声透颅植入物(SCI)的患者,涉及搭桥术后、脑积水分流术后、肿瘤切除术后及去骨瓣减压术后颅骨修补。所有研究均报告经SCI行超声成像可行且与标准影像可比;经SCI随访超声估计每例可节省至多4000美元。
要点
- 5项研究共90例SCI患者,所有研究均报告经SCI超声成像可行且与标准影像可比。
- 经SCI随访超声估计每例可节省至多4000美元,具体取决于手术类型。
- 作者认为经SCI超声是神经外科患者CT成像安全有效的替代选择。
核心结论
- 初步研究表明,经SCI行超声成像是神经外科患者CT成像的安全有效替代选择。
- 成本分析提示,SCI及后续超声与现行治疗相比可节省费用。
研究设计与样本
- 基于PRISMA指南的系统综述,检索获得226篇文章,最终纳入5项研究。
- 共分析90例非重复接受SCI的患者。
- 纳入患者病理:51例为颅外-颅内搭桥术后,37例为脑积水分流术后,1例为肿瘤切除术后,1例为去骨瓣减压术后颅骨修补。
- 提取信息包括疾病病理、超声成像可行性、与标准影像比较、感染及翻修;成本收集植入物价格与随访影像费用。
主要发现
- 所有研究均报告SCI置入后超声成像可行且与标准影像可比。
- 经SCI随访超声估计每例可节省至多4000美元,具体取决于手术类型。
临床怎么用
- 作者认为,经SCI超声成像可作为神经外科患者CT成像的安全有效替代选择。
- 作者指出,SCI及后续超声与现行治疗相比可节省费用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Computeed tomography (CT) is a cornerstone of the identification and management of acute changes in neurosurgery patients. In addition to the monetary expense of CT scans, further costs are incurred due to the time of patient transport and radiation exposure. Ultrasounds (USs)offer a safe, inexpensive, and bedside alternative to CT but obstacles remain due to decreased penetrance in the adult skull. Sonolucent Cranial Implants (SCIs) offer a window for USs to view intracranial architectures. METHODS: The authors performed a PRISMA guidelines-based systematic review of the literature. Information was extracted from included articles in regards to illness pathology, US imaging feasibility, comparison to standard imaging, infections, and revisions. Costs were collected in regards to price of implant and follow-up imaging. RESULTS: A total of 226 articles resulted, of which 5 were included in the study. Ninety non-duplicate patients who received SCIs were analyzed. The pathologies of included patients is as follows: 51 patients were after extracranial-intracranial bypass, 37 after ventriculoperitoneal shunt placement for hydrocephalus, 1 after tumor resection, and 1 after cranioplasty following decompressive hemicraniectomy. All studies noted feasibility of US and comparability to standard imaging following SCI placement. Follow-up imaging with trans-sonolucent cranial implant ultrasound was estimated to save up to $4,000 per patient depending on the procedure. CONCLUSIONS: Initial studies suggest that US imaging through SCIs is a safe and efficacious alternative to CT imaging in neurosurgical patients. Cost analysis suggests that SCI and subsequent US can offer a cost savings compared with current treatment.
引用
- O'Malley GR, Cassimatis ND, Maggio J, et al. Sonolucent Cranial Implants: A Window into the Future of Management of Neurosurgical Patients? A Systematic Review and Cost Analysis. World Neurosurg. 2023. PMID: 37931879. doi:10.1016/j.wneu.2023.10.145
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。